| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.16 | 9e-06 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.14 | 4e-05 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.14 | 4e-05 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0001 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.19 | 0.0005 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0008 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.001 |